KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biolife Solutions (BLFS) Gross Margin (2016 - 2025)

Historic Gross Margin for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to 90.99%.

  • Biolife Solutions' Gross Margin rose 27100.0% to 90.99% in Q3 2025 from the same period last year, while for Sep 2025 it was 89.91%, marking a year-over-year increase of 36700.0%. This contributed to the annual value of 88.32% for FY2024, which is 50700.0% up from last year.
  • As of Q3 2025, Biolife Solutions' Gross Margin stood at 90.99%, which was up 27100.0% from 89.25% recorded in Q2 2025.
  • In the past 5 years, Biolife Solutions' Gross Margin registered a high of 99.64% during Q4 2023, and its lowest value of 79.32% during Q3 2023.
  • Moreover, its 5-year median value for Gross Margin was 87.97% (2021), whereas its average is 88.15%.
  • As far as peak fluctuations go, Biolife Solutions' Gross Margin soared by 91600bps in 2023, and later tumbled by -95200bps in 2024.
  • Biolife Solutions' Gross Margin (Quarter) stood at 87.19% in 2021, then increased by 4bps to 90.48% in 2022, then increased by 10bps to 99.64% in 2023, then fell by -10bps to 90.12% in 2024, then rose by 1bps to 90.99% in 2025.
  • Its Gross Margin stands at 90.99% for Q3 2025, versus 89.25% for Q2 2025 and 89.15% for Q1 2025.